Dulaglutide
Trulicity (dulaglutide) is a protein pharmaceutical. Dulaglutide was first approved as Trulicity on 2014-09-18. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.
| Trade Name | Trulicity |
|---|---|
| Common Name | Dulaglutide |
| Indication | type 2 diabetes mellitus |
| Drug Class | Peptides: GLP peptide analogs |
